Pluvicto Europska Unija - hrvatski - EMA (European Medicines Agency)

pluvicto

novartis europharm limited  - lutetium (177lu) vipivotide tetraxetan - tumori prostate, Кастраци-uporan - terapeutski radiofarmaceutski pripravci - pluvicto in combination with androgen deprivation therapy (adt) with or without androgen receptor (ar) pathway inhibition is indicated for the treatment of adult patients with progressive prostate-specific membrane antigen (psma)-positive metastatic castration-resistant prostate cancer (mcrpc) who have been treated with ar pathway inhibition and taxane based chemotherapy.

Penthrox 99,9%, 3 ml para inhalata, tekućina Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

penthrox 99,9%, 3 ml para inhalata, tekućina

medical developments ned b.v., strawinskylaan 411, wtc tower a, amsterdam, nizozemska - metoksifluran - para inhalata, tekućina - 99,9%,3 ml - urbroj: jedna bočica sadrži 3 ml metoksiflurana (99,9%)

Cholib Europska Unija - hrvatski - EMA (European Medicines Agency)

cholib

viatris healthcare limited - fenofibrate, simvastatin - dislipidemije - sredstva za modifikaciju lipida - cholib je indiciran kao dodatna terapija dijeti i tjelovježbi u odraslih bolesnika visokim s mješovitim dislipidemijom za smanjenje triglicerida i povećanje razine hdl c kad ldl c razinama adekvatno upravlja pomoću odgovarajuće doze monoterapije simvastatinom.

Bemfola Europska Unija - hrvatski - EMA (European Medicines Agency)

bemfola

gedeon richter plc. - follitropin alfa - anovulacija - spolni hormoni i modulatori genitalnog sustava, - in adult women:anovulation (including polycystic ovarian disease, pcod) in women who have been unresponsive to treatment with clomiphene citrate;stimulation of multifollicular development in patients undergoing superovulation for assisted reproductive technologies (art) such as in vitro fertilisation (ivf), gamete intra-fallopian transfer (gift) and zygote intra-fallopian transfer (zift);follitropin alfa in association with a luteinising hormone (lh) preparation is recommended for the stimulation of follicular development in women with severe lh and fsh deficiency. u kliničkim istraživanjima kod ovih pacijenata su identificirani endogene razina lh u serumu < 1. 2 iu / l. in adult men:follitropin alfa is indicated for the stimulation of spermatogenesis in men who have congenital or acquired hypogonadotrophic hypogonadism with concomitant human chorionic gonadotrophin (hcg) therapy.

Humira Europska Unija - hrvatski - EMA (European Medicines Agency)

humira

abbvie deutschland gmbh co. kg - adalimumab - spondylitis, ankylosing; arthritis, juvenile rheumatoid; uveitis; colitis, ulcerative; psoriasis; arthritis, psoriatic; crohn disease; arthritis, rheumatoid - imunosupresivi - molimo pogledajte dokument s informacijama o proizvodu.

VITOPRIL H 10 mg/1 tableta+ 12.5 mg/1 tableta tableta Bosna i Hercegovina - hrvatski - Agencija za lijekove i medicinska sredstva Bosne i Hercegovine (Агенција за лијекове и медицинска средства Босне и Херцеговине)

vitopril h 10 mg/1 tableta+ 12.5 mg/1 tableta tableta

hemofarm proizvodnja farmaceutskih proizvoda d.o.o. banja luka - hidrohlorotiazid, lizinopril - tableta - 10 mg/1 tableta+ 12.5 mg/1 tableta - 1 tableta sadrži: 10 mg lizinoprila (u obliku lizinopril, dihidrata) 12,5 mg hidrohlorotiazida

VITOPRIL H 20 mg/1 tableta+ 12.5 mg/1 tableta tableta Bosna i Hercegovina - hrvatski - Agencija za lijekove i medicinska sredstva Bosne i Hercegovine (Агенција за лијекове и медицинска средства Босне и Херцеговине)

vitopril h 20 mg/1 tableta+ 12.5 mg/1 tableta tableta

hemofarm proizvodnja farmaceutskih proizvoda d.o.o. banja luka - hidrohlorotiazid, lizinopril - tableta - 20 mg/1 tableta+ 12.5 mg/1 tableta - 1 tableta sadrži: 20 mg lizinoprila (u obliku lizinopril, dihidrata) 12,5 mg hidrohlorotiazida